AARTI Industries Ltd stock analysis
Want to see IN:AARTIIND full AI Analyst Report?
AARTI Industries Ltd (AARTIIND) Stock Price & Analysis
AARTIIND Stock Chart & Stats
- Day’s Range
- INR 472.30 - INR 485.00
- 52-Week Range
- INR 338.20 - INR 551.45
- Previous Close
- INR 481.85
- Volume
- N/A
- Average Volume (3M)
- 53.03K
- Market Cap
- INR 174.79B
- Enterprise Value
- INR 219.57B
- Total Cash (Recent Filing)
- INR 4.95B
- Total Debt (Recent Filing)
- INR 51.86B
- Price to Earnings (P/E)
- 29.5
- Beta
- 1.13
- Next Earnings
- Feb 01, 2027 (Est.)
- EPS Estimate
- 4.6
- Last Dividend Ex-Date
- Sep 11, 2026
- Dividend Yield
- 0.21%
Bulls Say, Bears Say
Bulls Say
Revenue Recovery
The 2026 revenue rebound indicates improving demand after weaker prior periods and provides a stronger base for operating recovery. If sustained across the company’s end markets, renewed top-line growth can improve capacity utilization and support earnings expansion over the next several quarters.
Diversified End Markets
Exposure to multiple downstream industries reduces reliance on a single customer sector and broadens potential demand sources. This portfolio supports business resilience because weakness in one application can be partly offset by activity in other pharmaceutical, agricultural, polymer, or industrial markets.
Integrated Specialty Chemical Platform
An integrated manufacturing platform spanning intermediates and specialty chemicals gives Aarti Industries a broad base from which to serve customers across several applications. This operating model can support product breadth, customer continuity, and participation in higher-value chemical supply chains over time.
Bears Say
Weak Cash Conversion
The sharp operating cash-flow decline and persistently negative free cash flow show that reported profits are not translating into spendable cash. Continued weak conversion can constrain internally funded investment, increase dependence on financing, and reduce flexibility during periods of softer demand.
Rising Leverage
Higher borrowing has increased balance-sheet risk while operating cash flow covers only a limited portion of total debt. Greater leverage can raise financing pressure and reduce capital-allocation flexibility, particularly because current returns on equity are only about 7.0%.
Margin Compression
Profitability has weakened despite the revenue rebound, indicating lower earnings quality and reduced conversion of sales into profit. Sustained margin compression would limit earnings growth, make debt burdens harder to absorb, and leave less room to fund expansion or withstand operating volatility.
AARTI Industries Ltd News
AARTIIND FAQ
What was AARTI Industries Ltd’s price range in the past 12 months?
What is AARTI Industries Ltd’s market cap?
When is AARTI Industries Ltd’s upcoming earnings report date?
How were AARTI Industries Ltd’s earnings last quarter?
Is AARTI Industries Ltd overvalued?
Does AARTI Industries Ltd pay dividends?
What is AARTI Industries Ltd’s EPS estimate?
How many shares outstanding does AARTI Industries Ltd have?
What happened to AARTI Industries Ltd’s price movement after its last earnings report?
Which hedge fund is a major shareholder of AARTI Industries Ltd?
What is the TipRanks Smart Score and how is it calculated?
Company Description
AARTI Industries Ltd
Aarti Industries Limited, established in 1984 and headquartered in Mumbai, India, is a prominent manufacturer and supplier of both specialty chemicals and pharmaceutical products. The company's chemical division produces a wide array of compounds including dichlorobenzene, various nitro-chloro and nitro-benzene derivatives, nitro-toluenes, and sulfur, along with other organic and inorganic substances. These crucial materials serve as intermediates for a diverse range of sectors such as agrochemicals, pharmaceuticals, polymer and fuel additives, fast-moving consumer goods (FMCG), dyes, pigments, paints, printing inks, rubber chemicals, and resins. In the pharmaceutical sphere, Aarti Industries develops active pharmaceutical ingredients (APIs) utilized in medications for conditions like hypertension, asthma, cancer, thalassemia, pain relief, ophthalmic disorders, and central nervous system agents, as well as skincare and decongestant products. They also supply pharmaceutical intermediates and a selection of xanthine derivatives, prominently featuring caffeine anhydrous, theophylline, and related compounds. Beyond its manufacturing capabilities, Aarti Industries provides contract manufacturing and research services. The company maintains a significant global presence, exporting its products to approximately 60 countries across North America, Europe, China, Japan, and other international regions.
- Sector
- General
- Industry
- Chemicals - Specialty
- CEO
- Suyog Kalyanji Kotecha
- Employees
- 6,100
- Website
- www.aarti-industries.com
- Address
- 71, Udyog Kshetra, Mumbai, MA, 400 080, IN
AARTI Industries Ltd (AARTIIND) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 3 | 5 |
| Technical Analysis | 3 | 3 | 4 |
| Moving Averages | 11 | 0 | 1 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| IN:AETHERAether Industries Ltd. | ||
| IN:ANURASAnupam Rasayan India Ltd. | ||
| IN:ATULAtul Limited | ||
| IN:FINEORGFine Organic Industries Ltd. | ||
| IN:VINATIORGAVinati Organics Limited |










